<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
<title>O. Kretchikova, G. Reshedko, O. Stetsiouk, O. Egorova, T. Bogdanovich, L. Stratchounski - Nasopharyngeal Carriage Rate and Susceptibility of Haemophilus influenzae to Antimicrobials in Central Part of Russia</title>
<meta name="description" content="Nasopharyngeal Carriage Rate and Susceptibility of Haemophilus influenzae to Antimicrobials in Central Part of Russia">
<meta name="keywords" content="nasopharyngeal, carriage rate, susceptibility, Haemophilus influenzae, antimicrobials, Kretchikova, Reshedko, Stetsiouk, Egorova, Bogdanovich, Stratchounski">
<script language="JavaScript1.2"> <!--//
function btn(ind,picture) {document.images[ind].src=picture;}
//--> </script>

<script language="JavaScript"> <!--// 
document.write('<link rel="StyleSheet" type="text/css" href="/en/inc/');
if (navigator.appName=="Netscape") {
	document.write("nn")
} else {
	document.write("ie")
}
document.write('.css">');
//-->
</script>
<noscript><link rel="StyleSheet" type="text/css" href="../../inc/ie.css"></noscript>

<style type="text/css">
P {margin-top: 10px; margin-left: 10px; text-align: justify;}
LI {margin-top: 8px; margin-left: 15px; text-align: justify;}
H4 {margin-left: 10px;}
H5 {font-size: 11pt}
H5.l {text-align: left;}
</style>
</head>

<body class="main">

<table width="750" cellpadding="0" border="0" cellspacing="5">
<tr>
  <th width="150" valign="top">

  <table border="0" cellpadding="5" cellspacing="0" width="100%">
    <tr><td>
<p class="m10"><b>Antimicrobial Resistance</b></p>
<hr size="1" style="color: #D0C0AC;">
<p class="m8"><a href="../index.shtml#rus">Antimicrobial Resistance in Russia</a></p>
<p class="m8"><a href="../index.shtml#pub">Publications</a></p>
<p class="m8"><a href="../links.shtml">References</a></p>

    </td></tr>
  </table>
  

  </th><td valign="top">
<!--navigation-->
<map name="TopBtnEn">
<area shape="circle" coords="15,15,15" href="javascript:history.go(-1)" alt="Previous page" title="Previous page">
<area shape="circle" coords="46,15,15" href="javascript:history.go(+1)" alt="Next page" title="Next page">
<area shape="circle" coords="77,15,15" href="../../index-1.htm" alt="Main page" title="Main page">
<area shape="circle" coords="108,15,15" href="mailto:website@antibiotic.ru" alt="E-Mail" title="E-Mail">
</map>
<table border="0" cellpadding="0" cellspacing="0" width="100%"> <!--1-->
<tr>
  <td bgcolor="#F8F3E6" background="/rus/images/buttons/topline.gif" style="background-color: #F8F3E6; background-image: url(../../../rus/images/buttons/topline.gif);" width="98%" height="32"><img src="../../../rus/images/inv.gif" width="1" height="32" border="0" alt=""></td>
  <td width="1%"><font size="1"><img src="../../../rus/images/buttons/topbtn.gif" width="126" height="32" border="0" alt="Navigation" usemap="#TopBtnEn"></font></td>
</tr>
</table>
<!--/navigation-->


<h2><a name="top"></a>9<sup>th</sup> European Congress of Clinical Microbiology and Infectious Diseases</h2>
<h5><i>21-25 March, 1999, Berlin, Germany</i><br>
<b>Poster # P0581</b></h5>

<h1>Nasopharyngeal Carriage Rate and Susceptibility of <i>Haemophilus influenzae</i> to Antimicrobials<br>in Central Part of Russia</h1>

<h5><i>O.&nbsp;KRETCHIKOVA, <u>G.&nbsp;RESHEDKO</u>, O.&nbsp;STETSIOUK, O.&nbsp;EGOROVA, T.&nbsp;BOGDANOVICH, L.&nbsp;STRATCHOUNSKI</i></h5>

<h5 class="l"><i>Department of Clinical Pharmacology &amp; Antimicrobial Chemotherapy, Smolensk State Medical Academy</i></h5>

<p style="text-align:right; font-size:8pt"><a href="../../pdfs/p0581.pdf">The PDF format poster (332 kb) <img src="../../images/pdf.gif" width="16" height="16" alt="" border="0"></a></p>

<hr size="1">
<ul>
   <li><a href="#1">Abstract</a></li>
   <li><a href="#2">Introduction and purpose</a></li>
   <li><a href="#3">Materials and methods</a></li>
   <li><a href="#4">Results and discussion</a></li>
   <li><a href="#5">Conclusions</a></li>
</ul>
<hr size="1">

<a name="1"></a><br>
<h2>ABSTRACT</h2>

<p><b>Objectives:</b> To evaluate the rate of nasopharyngeal carriage of <i>Haemophilus influenzae</i> (Hif) among the children of 1-6 years old from the day-care centres in central region of Russia and to elucidate the current resistance patterns of Hif.</p>

<p><b>Methods:</b> A total of 733 children from Moscow, Smolensk and Yartstevo were included into this study. Nasopharyngeal cultures were collected using sterile cotton swabs. Isolates were identified with Gram stain, oxidase, X+V factors. MICs were determined with Etests method. Agents tested were ampicillin (AM), amoxicillin/clavulanate (XL), cefaclor (CF), erythromycin (ER), clarithromycin (CH), roxithromycin (RO) and co-trimoxazole (TS). <font face="Symbol">b</font>-lactamase testing was performed with nitrocefin. Quality control was performed using <i>H.influenzae</i> ATCC 49247 and ATCC 49766. </p>

<p><b>Results:</b> A total nasopharyngeal carriage rate of Hif was 44%, varying from 32% in Moscow to 46% and 55% in Yartstevo and Smolensk respectively. Only 2% of the strains were resistant to AM and 0.6% to XL and CF. Of 3 AM-resistant strains 1 strain was <font face="Symbol">b</font>-lactamase-positive. Both ER and RO demonstrated very low activity against Hif (R%/I% were 12/88 and 97.9/2.1 respectively). The CH-resistance rate was 18.7%. The highest level of resistance registered was for TS (20.9%).</p>

<p><b>Conclusion:</b> There is a low prevalence of both <font face="Symbol">b</font>-lactamase-positive and <font face="Symbol">b</font>-lactamase-negative AM-resistant strains in children from central part of Russia. AM remains the drug of choice for treatment of Hif infections. However, it is necessary to continue surveillance of AM-resistance in regions participated. Of all tested macrolides only CH had notable activity against Hif.</p>

<a name="2"></a><br>
<h2>INTRODUCTION AND PURPOSE</h2>

<p><i>H.influenzae</i> causes various infections. Data obtained from various studies have demonstrated that antibiotic resistance in <i>H.influenzae</i> had reached epidemic proportions and varies greatly in different regions of the world. Nasopharyngeal colonisation of children reflects the strains currently circulating in the community and causing infections.</p>

<p>The purpose of the study was to investigate the carriage rate and the susceptibility of nasopharyngeal strains of <i>H.influenzae</i> to <font face="Symbol">b</font>-lactams, macrolides and co-trimoxazole.</p>

<a name="3"></a><br>
<h2>MATERIALS AND METHODS</h2>

<p>Nasopharyngeal strains of <i>H.influenzae</i> were collected during 1997 from healthy children attending day-care centers in Moscow, Smolensk and Yartstevo. Isolation and identification were done according standard methods. Susceptibility testing was done with E-tests (AB Biodisk, Sweden). The antibiotics tested were ampicillin (AM), amoxicillin/clavulanate (XL), cefaclor (CF), erythromycin (ER), clarithromycin (CH), roxithromycin (RO) and co-trimoxazole (TS). H.influenzae strains were tested on Haemophilus Test Medium (Oxoid, UK), inoculum 0.5 McFarland, incubation for 16-18 h at 35<sup>o</sup>C with 5% CO<sub>2</sub>. <i>H.influenzae</i> ATCC 49247 and 49766 strains were used for quality control. Interpretation of susceptibility results was performed according to criteria of NCCLS-97 (USA) for <font face="Symbol">b</font>-lactams, clarithromycin and co-trimoxazole and SFM-96 (France) for erythromycin and roxithromycin. Data were calculated using software M-Lab.</p>

<a name="4"></a><br>
<h2>RESULTS AND DISCUSSION</h2>

<p>A total of 733 children were included into this study. The nasopharyngeal carriage rate of <i>H.influenzae</i> was 44% varying from 32% in Moscow to 55% and 46% in Smolensk and Yartstevo respectively. In total 323 <i>H.influenzae</i> strains were isolated, 300 from these were tested to the studied antimicrobials. The antimicrobial activity of tested drugs against nasopharyngeal isolates of <i>H.influenzae</i> are indicated in the following table.</p>

<a name="t1"></a><br>
<p><b>Table 1.</b> The <i>in-vitro</i> activity of antimicrobials against nasopharyngeal strains of <i>H.influenzae</i></p>

<table border="0" cellpadding="0" cellspacing="10" width="100%"><tr><td bgcolor="#CC9988">
<table width="100%" cellpadding="5" cellspacing="1" border="0">
<tr>
	<th rowspan="2">Antimicrobials</th>
	<th colspan="2">Breakpoints</th>
	<th rowspan="2">N of<br>strains</th>
	<th rowspan="2">%R</th>
	<th rowspan="2">%I</th>
	<th rowspan="2">%S</th>
	<th rowspan="2">MIC<sub>50</sub></th>
	<th rowspan="2">MIC<sub>90</sub></th>
	<th rowspan="2">MIC Range</th>
</tr>
<tr>
	<th>S</th>
	<th>R</th>
</tr>
<tr>
	<td class="cl">Ampicillin</td>
	<td class="cc"><u>&lt;</u>1</td>
	<td class="cc"><u>&gt;</u>4</td>
	<td class="cc">300</td>
	<td class="cc">0,9</td>
	<td class="cc">1,2</td>
	<td class="cc">97,9</td>
	<td class="cc">0,19</td>
	<td class="cc">0,38</td>
	<td class="cc">0,016-128</td>
</tr>
<tr>
	<td class="cl">Amoxicillin/ clavulanate</td>
	<td class="cc"><u>&lt;</u>4/2</td>
	<td class="cc"><u>&gt;</u>8/4</td>
	<td class="cc">300</td>
	<td class="cc">0,6</td>
	<td class="cc">0</td>
	<td class="cc">99,4</td>
	<td class="cc">0,5</td>
	<td class="cc">1</td>
	<td class="cc">0,016-8</td>
</tr>
<tr>
	<td class="cl">Cefaclor</td>
	<td class="cc"><u>&lt;</u>8</td>
	<td class="cc"><u>&gt;</u>32</td>
	<td class="cc">300</td>
	<td class="cc">0,6</td>
	<td class="cc">0</td>
	<td class="cc">99,4</td>
	<td class="cc">1</td>
	<td class="cc">3</td>
	<td class="cc">0,25-32</td>
</tr>
<tr>
	<td class="cl">Erythromycin</td>
	<td class="cc"><u>&lt;</u>1</td>
	<td class="cc"><u>&gt;</u>4</td>
	<td class="cc">300</td>
	<td class="cc">12,0</td>
	<td class="cc">88,0</td>
	<td class="cc">0</td>
	<td class="cc">4</td>
	<td class="cc">8</td>
	<td class="cc">1-16</td>
</tr>
<tr>
	<td class="cl">Clarithromycin</td>
	<td class="cc"><u>&lt;</u>8</td>
	<td class="cc"><u>&gt;</u>32</td>
	<td class="cc">300</td>
	<td class="cc">0</td>
	<td class="cc">18,7</td>
	<td class="cc">81,3</td>
	<td class="cc">6</td>
	<td class="cc">12</td>
	<td class="cc">1-24</td>
</tr>
<tr>
	<td class="cl">Roxithromycin</td>
	<td class="cc"><u>&lt;</u>1</td>
	<td class="cc"><u>&gt;</u>4</td>
	<td class="cc">300</td>
	<td class="cc">97,9</td>
	<td class="cc">2,1</td>
	<td class="cc">0</td>
	<td class="cc">16</td>
	<td class="cc">32</td>
	<td class="cc">4-128</td>
</tr>
<tr>
	<td class="cl">Co-trimoxazole</td>
	<td class="cc"><u>&lt;</u>0,5/9,5</td>
	<td class="cc"><u>&gt;</u>4/76</td>
	<td class="cc">300</td>
	<td class="cc">20,3</td>
	<td class="cc">0,6</td>
	<td class="cc">79,1</td>
	<td class="cc">0,125</td>
	<td class="cc">32</td>
	<td class="cc">0,016-32</td>
</tr>
</table>
</td></tr></table>

<p>Only 2,1% of the tested strains were resistant to ampicillin (including R and I) and 0.6% to amoxicillin/clavulanate and cefaclor. Only one of the 3 ampicillin-resistant strains was <font face="Symbol">b</font>-lactamase-positive (nitrocefin test) and susceptible to amoxicillin/clavulanate and cefaclor. The level of <font face="Symbol">b</font>-lactamase-production in strains isolated in our study (0,3%) was significantly lower than in United States (19,7-37,9%) and in Eastern Europe (9,0-19,5%) (Doern <i>et al</i>., 1996).</p>

<p>The other two resistant strains were <font face="Symbol">b</font>-lactamase-negative ampicillin-resistant (BLNAR) and resistant to amoxicillin/clavulanate and cefaclor what may be due to the production of altered forms of penicillin-binding proteins or decreased permeability of the cell wall. It is worth to note that ampicillin-resistant (R) strains were isolated only in Smolensk, all strains from Yartstevo were ampicillin-susceptible.</p>

<p>Both erythromycin and roxithromycin demonstrated very low <i>in vitro</i> activity against <i>H.influenzae</i> (R%/I% were 12,0/88,0 and 97,9/2,1 respectively). However most strains had intermediate level of resistance to erythromycin with MIC<sub>50</sub>/MIC<sub>90</sub> - 4/8 mg/L. The clarithromycin resistance rate was 18.7%, despite MIC<sub>50</sub>/MIC<sub>90</sub> of this drug were some higher than of erythromycin (6/12 mg/L).</p>

<p>The highest level of resistance was registered for co-trimoxazole (20.9%). That exceeds the rates reported in European countries (0-12%) and United States (0-4.3%) (Doern <i>et al</i>., 1996). Probably the high rate of co-trimoxazole resistance is due to frequent administration of the drug in ambulatory practice in Russia.</p>

<a name="5"></a><br>
<h2>CONCLUSIONS</h2>

<ul>
	<li>The low prevalence of both <font face="Symbol">b</font>-lactamase-positive and BLNAR nasopharyngeal isolates of <i>H.influenzae</i> suggests that aminopenicillins remain the drugs of choice for the treatment of infections caused by <i>H.influenzae</i> in central part of Russia.</li>
	<li>Of all tested macrolides only clarithromycin has notable activity against <i>H.influenzae</i>.</li>
	<li>Co-trimoxazole probably should be avoided as the drug of empirical choice because of high prevalence of resistant strains.</li>
</ul>

<hr size="1">

<br>
<!-- begin footer -->
<table border="0" cellpadding="5" cellspacing="0" width="100%">
<tr>
  <td style="text-align: left; vertical-align: bottom;" align="left" valign="bottom"><div class="t8">&copy; 2000-2006 IAC SSMA &middot; E-mail: <a href="mailto:website@antibiotic.ru" title="Send e-mail">website&#64;antibiotic&#46;ru</a></div></td>
  <td colspan="2" valign="top" align="right"><font size="1"><!-- SpyLOG v2 f:0211 --><script language="javascript">
u="u607.38.spylog.com";d=document;nv=navigator;na=nv.appName;p=1;
bv=Math.round(parseFloat(nv.appVersion)*100);
n=(na.substring(0,2)=="Mi")?0:1;rn=Math.random();z="p="+p+"&rn="+rn;y="";
y+="<a href='http://"+u+"/cnt?f=3&p="+p+"&rn="+rn+"' target=_blank>";
y+="<img src='http://"+u+"/cnt?"+z+
"&r="+escape(d.referrer)+"&pg="+escape(window.location.href)+"' border=0  width=88 height=31  alt='SpyLOG'>";
y+="</a>"; d.write(y);if(!n) { d.write("<"+"!--"); }//--></script><noscript>
<a href="../../../index-15.htm?f=3&p=1" target="_blank">
<img src="../../../digits.png?p=1" alt='SpyLOG' border='0' width="88" height="31">
</a></noscript><script language="javascript1.2"><!--
if(!n) { d.write("--"+">"); }//--></script><!-- SpyLOG  --></font></td>
</tr>
</table>
<!-- end of footer -->

  </td></tr>
</table>
</body>
</html>
